iCardio.ai
About iCardio.ai
iCardio.ai is a Los Angeles-based healthcare AI company dedicated to revolutionizing cardiac diagnostics through advanced machine learning and deep learning algorithms applied to ultrasound imaging, specifically echocardiography. The company’s core mission is to automate the entire echocardiogram workflow, from image acquisition to comprehensive diagnosis, thereby enhancing diagnostic accuracy, consistency, and efficiency for clinicians. Their proprietary AI models, trained on an extensive database of over 200 million ultrasound images, perform segmentation, classification, and regression analysis to interpret echocardiograms with high precision.
Key offerings include EchoMeasure™, which has received U.S. FDA 510(k) clearance, providing an automated, comprehensive imaging workflow and preliminary reporting tool for various cardiac measurements. Additionally, their CardioVision™ AI, an aortic stenosis detection tool, has earned FDA Breakthrough Device Designation, addressing critical unmet needs in identifying this severe valvular heart disease. iCardio.ai’s technology aims to streamline clinical workflows, reduce inter-operator variability, and enable earlier, more confident diagnostic decisions, ultimately leading to improved patient outcomes in conditions such as valvular heart disease, heart failure, and coronary artery disease.
The company actively collaborates with leading ultrasound hardware and software providers, including GE Healthcare, Butterfly Network, UltraLinQ, and SARC MedIQ, to integrate its AI solutions into existing platforms and expand accessibility globally. Future plans include enhancing intracardiac echocardiography capabilities and developing EchoGPT, an AI-powered tool for autonomous generation of complete echocardiography reports.
Focus Areas
Business Intelligence
| Key Investors | HeartX, MedAxiom, HealthTech Arkansas, BSD Enterprises, Jerusalem Venture Partners, The Roddenberry Foundation, Cove Fund, CONNECT, Techstars |
| Partnerships | GE Healthcare, UltraLinQ, SARC MedIQ, Abbott, Butterfly Network, Viz.ai, Clarius, deepc, Arkansas Heart Hospital, Conway Regional |
| Technology | Machine learning and deep learning algorithms, Proprietary database of over 200 million ultrasound images, AI processing pipelines, NVIDIA Clara Holoscan (for real-time processing at the edge), API for integration |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
iCardio.ai's solutions are designed to significantly enhance diagnostic accuracy and efficiency, allowing for earlier detection of critical conditions like severe aortic stenosis. By automating over 60 echocardiographic measurements and providing preliminary reports, their technology streamlines workflows, reduces sonographer fatigue, and minimizes diagnostic variability. Physicians can expect more confident decision-making, improved patient outcomes, and more time for direct patient interaction. The AI also offers objective image quality assessment and is built for seamless integration into existing PACS and DICOM workflows, ensuring a smooth transition into clinical practice.
iCardio.ai emphasizes seamless integration with existing medical imaging workflows, including PACS, DICOM viewers, and imaging worklists, through a simple and straightforward API. They have established key partnerships with major healthcare organizations and ultrasound vendors such as GE Healthcare, Abbott, UltraLinQ, SARC MedIQ, deepc, and Viz.ai, to integrate their technology into various platforms and broaden accessibility.
What the Web Says
iCardio.ai is a Los Angeles-based company specializing in AI and deep learning algorithms for ultrasound analysis, particularly in transthoracic echocardiography. They aim to automate echocardiography measurements, detect conditions like aortic stenosis, and generate faster, more accurate reports using FDA-cleared AI tools. The company leverages a proprietary database of over 200 million ultrasound images to enhance diagnostic accuracy and efficiency.
Overall: PositiveStrengths
- Automated echocardiography measurements and reporting, leading to increased efficiency and speed.
- Improved diagnostic accuracy and consistency for cardiac conditions like aortic stenosis.
- FDA 510(k) clearance for EchoMeasureu2122 and FDA Breakthrough Device Designation for CardioVisionu2122 (aortic stenosis detection tool).
- Seamless integration with existing medical imaging systems and platforms through a straightforward API.
- Partnerships with major healthcare organizations like GE Healthcare, UltraLinQ, and SARC MedIQ, broadening accessibility.
- Positive employer reviews on Indeed.com, highlighting a great place to learn new skills and work independently.
Limitations
- Limited public product reviews available on major platforms like G2, Capterra, and Product Hunt.
- G2 lists iCardio.ai alternatives, suggesting potential competition or areas for improvement in reliability and ease of use compared to top-rated tools.
- Reddit discussions on AI in echocardiography raise general concerns about accuracy, training, trust in technology, and the potential impact on the role of echocardiographers.
- One Indeed review for 'Icario' (a different company, but a similar name) mentions last-minute requirement changes and leadership issues, which could be a point of confusion for job seekers.
- Some Reddit users express skepticism or negative experiences with cardiologists and the adoption of new technologies in general, which could indirectly affect perception of AI solutions.
Based on reviews from: iCardio.ai, Top 10 Icardio.AI Alternatives & Competitors in 2026 - G2, iCardio.ai: AI ultrasound analysis for echo reports - Product Hunt, HeartX Success Story: iCardio.ai - MedAxiom, AI-driven tools into echocardiography practice : r/cardiacsonography - Reddit, iCardio Careers and Employment | Indeed.com, Viz.ai and iCardio.ai Partner on Aortic Stenosis Detection Using Ultrasound Imaging and Artificial Intelligence, AI proved superior in assessing and diagnosing cardiac function when compared with echocardiogram assessments made by sonographers : r/science - Reddit, Sonographer at iCardio | Indeed.com, AI-Driven Computer Vision Transforms Echocardiogram Analysis for Icardio.AI, Enhancing Precision and Speed - GenAI Labs, New AI models can accurately diagnose complex heart conditions without a cardiologist, providing vital support in underserved areas. : r/ArtificialInteligence - Reddit, I tried all the AI medical scribes so you don't have to - my honest review - Reddit, Cardiology-Cloud Software Pricing, Alternatives & More 2026 | Capterra, Best AI Medical Diagnostic Platforms: User Reviews from July 2026 - G2, Best AI Patient Engagement & Operations Software: User Reviews from July 2026 - G2, Page 2 | Best Cardiology EMR Software 2026 - Capterra, Best Medical Coding Software: User Reviews from July 2026 - G2, Cardio app went exactly as expected. How disappointing : r/POTS - Reddit, iCare Reviews 2026. Verified Reviews, Pros & Cons | Capterra, iCare Software Pricing, Alternatives & More 2026 | Capterra, Working at Icario: Employee Reviews | Indeed.com, Best Speech Analytics Software: User Reviews from July 2026 - G2, Working at Chicago Cardiology Institute: 50 Reviews | Indeed.com
Last updated: 2026-07-18
Videos
News, demos, and interviews about iCardio.ai.
Videos load interactively. If none appear, search YouTube for iCardio.ai →
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]